4-butyrolactone has been researched along with Acute Liver Injury, Drug-Induced in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abdallah, HM; Abdel-Naim, AB; Alamoudi, AJ; Eid, BG; Ibrahim, SRM; Kammoun, AK; Mohamed, GA; Shaik, RA; Sirwi, A | 1 |
Ho, HY; Hsieh, CC; Lin, WC; Lin, WL; Tsay, HS; Wu, JB | 1 |
2 other study(ies) available for 4-butyrolactone and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Mokko Lactone Attenuates Doxorubicin-Induced Hepatotoxicity in Rats: Emphasis on Sirt-1/FOXO1/NF-κB Axis.
Topics: 4-Butyrolactone; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Doxorubicin; Glutathione; Liver; Malondialdehyde; Nerve Tissue Proteins; NF-kappa B; Rats; Sesquiterpenes; Signal Transduction; Sirtuin 1; Superoxide Dismutase | 2021 |
The hepatoprotective activity of kinsenoside from Anoectochilus formosanus.
Topics: 4-Butyrolactone; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Lethal Dose 50; Male; Mice; Monosaccharides; Orchidaceae; Phytotherapy; Plant Extracts; Protective Agents | 2007 |